All News #Library
Biotech
Essential Pharma Acquires Renaissance for Neuroblastoma Therapy.
09 Apr 2024 //
GLOBENEWSWIRE
Renaissance Pharma launches today & announces the in-licensing of Hu14.18K322A
01 Aug 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support